Latest News

New Science Funding Numbers Likely on Hold Until Post-Election

Congress is in the midst of a seven-week recess. When Members of Congress return in September, they will need to pass a Continuing Resolution (CR) to continue funding the government on October 1, 2016, the beginning of Fiscal Year 2017.
From the NIA

The National Institute on Aging recently posted a number of "pre-advertisements" regarding several job vacancies.

Welcome from the President

SBN President Cheryl Sisk.

GREETINGS TO ALL SBN MEMBERS!
I am delighted and honored to be your new President. SBN is a wonderful organization that provides significant benefits to its members. I look forward to helping the society meet your interests and needs in science and professional development, and I encourage you to share your ideas about how SBN can best serve you.

—Elizabeth Adkins-Regan

Upcoming Meetings

Become a Member of the SBN

The Society for Behavioral Neuroendocrinology offers four levels of eligibility for prospective members: Regular, Emeritus, Student, or Associate Memberships.

To see which membership class you qualify for, please review the membership eligibility requirements.

For additional information on SBN and the rules of membership, please see the SBN Bylaws.

join now

Elected Officers

PRESIDENT (2015-2017) Elizabeth Adkins-Regan

PRESIDENT-ELECT (2015-20175) Rae Silver

PAST PRESIDENT (2015-2017) Cheryl Sisk

SECRETARY (2015-2017) Colin John Saldanha

TREASURER (2013-2016) Nancy Forger

view more

Hormones and Behavior

Thursday, August 25, 2016
Publication date: September 2016
Source:Hormones and Behavior, Volume 85

Author(s): Martha C. Washington, Thaer R. Mhalhal, Ayman I. Sayegh

This confirmatory work is aimed to test that the hypothesis that the gastrin releasing peptide (GRP) receptor – the BB2 receptor – is necessary for reduction of meal size (MS) and prolongation of the intermeal interval (IMI) by the small and the large forms of GRP in the rat, GRP-10 and GRP-29, and to confirm the sites of action regulating such responses – the vascular bed of the celiac artery (CA, supplying stomach and upper duodenum). To pursue these aims we measured first MS and IMI length in response to GRP-10 and GRP-29 (0, 0.5nmol/kg) infused in the CA (n =8 rats) and the cranial mesenteric artery (CMA, supplying the small and part of the large intestine, n =8 rats) in near spontaneously free feeding rats pretreated with the BB2 receptor antagonist BW2258U89 (0.1mg/kg) in the same arteries prior to the onset of the dark cycle. We found that GRP-29, but not GRP-10, infused by the CA reduced MS and prolonged the IMI by decreasing meal latency and meal duration and the BB2 receptor antagonist BW2258U89 infused in the same artery attenuated these responses. These results suggest that the BB2 receptor is necessary for reduction of MS and prolongation of the IMI by exogenous GRP-29, and the vascular bed of the CA, stomach and upper duodenum, contains sites of action regulating these feeding responses.

Thursday, August 25, 2016
Publication date: September 2016
Source:Hormones and Behavior, Volume 85

Author(s): Lena Wallensteen, Marius Zimmermann, Malin Thomsen Sandberg, Anton Gezelius, Anna Nordenström, Tatja Hirvikoski, Svetlana Lajic

Prenatal dexamethasone (DEX) treatment in congenital adrenal hyperplasia (CAH) is effective in reducing virilization in affected girls, but other lasting effects are largely unknown. Here, we explore potential side effects of the treatment that will eventually help to make risk benefit analyses of the treatment. Therefore, we investigated the long-term effects of such prenatal DEX treatment on behavioral problems and temperament in children aged 7–17years. Standardized parent-completed questionnaires were used to evaluate adaptive functioning, behavioral and emotional problems (using CBCL), social anxiety (SPAI-C-P), and temperament (EAS). Self-reports were used to assess the children's own perception of social anxiety (SASC-R). The study compared 34 DEX-treated children and adolescents who were treated during the first trimester of fetal life and do not have CAH with 66 untreated controls from the Swedish population. No statistically significant differences were found between groups, suggesting that healthy children who were treated with DEX during early fetal life seem to be well adjusted without major behavioral or emotional problems as assessed by their parents. Moreover, self-reported social anxiety was not increased in DEX-exposed children and adolescents. In fact, the control group scored higher on items assessing anxiety in new, social situations. Nevertheless, for some of these comparisons, non-significant moderate to large effect sizes were observed, implying that the null findings should be interpreted with caution and require studies on larger, internationally combined cohorts.

Thursday, August 25, 2016
Publication date: September 2016
Source:Hormones and Behavior, Volume 85

Author(s): Huimin Zheng, Keith M. Kendrick, Rongjun Yu

People may choose non-cooperation in social dilemmas either out of fear (if others choose to defect) or out of greed (when others choose to cooperate). Previous studies have shown that exogenous oxytocin motivates a “tend and defend” pattern in inter-group conflict in which oxytocin stimulates in-group cooperation and out-group defense. Using a double-blind placebo-controlled design combined with a modified Prisoner's dilemma game (PDG), we examined the effect of oxytocin on social motivations in inter-individual conflict in men. Results showed that compared with the placebo group, oxytocin-exposed participants were less cooperative in general. Specifically, oxytocin amplified the effect of fear on defection but did not influence the effect of greed. Another non-social control study confirmed participants' decisions were sensitive to social factors. Our findings suggest that even when social group conflict is removed, oxytocin promotes distrust of strangers in “me and you” inter-individual conflict by elevating social fear in men.

learn more